Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 112

Similar articles for PubMed (Select 23771160)


Tumor-infiltrating lymphocytes in colorectal tumors display a diversity of T cell receptor sequences that differ from the T cells in adjacent mucosal tissue.

Sherwood AM, Emerson RO, Scherer D, Habermann N, Buck K, Staffa J, Desmarais C, Halama N, Jaeger D, Schirmacher P, Herpel E, Kloor M, Ulrich A, Schneider M, Ulrich CM, Robins H.

Cancer Immunol Immunother. 2013 Sep;62(9):1453-61. doi: 10.1007/s00262-013-1446-2. Epub 2013 Jun 16.


Alterations in the signal-transducing molecules of T cells and NK cells in colorectal tumor-infiltrating, gut mucosal and peripheral lymphocytes: correlation with the stage of the disease.

Matsuda M, Petersson M, Lenkei R, Taupin JL, Magnusson I, Mellstedt H, Anderson P, Kiessling R.

Int J Cancer. 1995 Jun 9;61(6):765-72.


Analysis of the T cell receptor variability of tumor-infiltrating lymphocytes in colorectal carcinomas.

Baier PK, Wimmenauer S, Hirsch T, von Specht BU, von Kleist S, Keller H, Farthmann EH.

Tumour Biol. 1998;19(3):205-12.


T-cell receptor repertoire in matched MART-1 peptide-stimulated peripheral blood lymphocytes and tumor-infiltrating lymphocytes.

Cole DJ, Wilson MC, Rivoltini L, Custer M, Nishimura MI.

Cancer Res. 1997 Dec 1;57(23):5320-7.


T cell responses against microsatellite instability-induced frameshift peptides and influence of regulatory T cells in colorectal cancer.

Bauer K, Nelius N, Reuschenbach M, Koch M, Weitz J, Steinert G, Kopitz J, Beckhove P, Tariverdian M, von Knebel Doeberitz M, Kloor M.

Cancer Immunol Immunother. 2013 Jan;62(1):27-37. doi: 10.1007/s00262-012-1303-8. Epub 2012 Jun 23.


Evidence for existence of oligoclonal tumor-infiltrating lymphocytes and predominant production of T helper 1/T cytotoxic 1 type cytokines in gastric and colorectal tumors.

Matsutani T, Shiiba K, Yoshioka T, Tsuruta Y, Suzuki R, Ochi T, Itoh T, Musha H, Mizoi T, Sasaki I.

Int J Oncol. 2004 Jul;25(1):133-41.


Colorectal cancer prognosis depends on T-cell infiltration and molecular characteristics of the tumor.

Dahlin AM, Henriksson ML, Van Guelpen B, Stenling R, Oberg A, Rutegård J, Palmqvist R.

Mod Pathol. 2011 May;24(5):671-82. doi: 10.1038/modpathol.2010.234. Epub 2011 Jan 14.


High-level expression of chemokine CXCL16 by tumor cells correlates with a good prognosis and increased tumor-infiltrating lymphocytes in colorectal cancer.

Hojo S, Koizumi K, Tsuneyama K, Arita Y, Cui Z, Shinohara K, Minami T, Hashimoto I, Nakayama T, Sakurai H, Takano Y, Yoshie O, Tsukada K, Saiki I.

Cancer Res. 2007 May 15;67(10):4725-31.


T-cell receptor V-gene usage in neoplasms of the central nervous system. A comparative analysis in cultured tumor infiltrating and peripheral blood T cells.

Merlo A, Filgueira L, Zuber M, Juretic A, Harder F, Gratzl O, De Libero G, Heberer M, Spagnoli GC.

J Neurosurg. 1993 Apr;78(4):630-7.


Comparison of T-cell receptor repertoire restriction in blood and tumor tissue of colorectal cancer patients.

Ochsenreither S, Fusi A, Wojtke S, Busse A, Nüssler NC, Thiel E, Keilholz U, Nagorsen D.

J Transl Med. 2010 Apr 12;8:35. doi: 10.1186/1479-5876-8-35.


Dendritic cell and macrophage infiltration in microsatellite-unstable and microsatellite-stable colorectal cancer.

Bauer K, Michel S, Reuschenbach M, Nelius N, von Knebel Doeberitz M, Kloor M.

Fam Cancer. 2011 Sep;10(3):557-65. doi: 10.1007/s10689-011-9449-7.


Heterogeneous expansion of CD4+ tumor-infiltrating T-lymphocytes in clear cell renal cell carcinomas.

Zhang Q, Jia Q, Deng T, Song B, Li L.

Biochem Biophys Res Commun. 2015 Feb 27;458(1):70-6. doi: 10.1016/j.bbrc.2015.01.069. Epub 2015 Jan 28.


Signaling abnormalities, apoptosis, and reduced proliferation of circulating and tumor-infiltrating lymphocytes in patients with oral carcinoma.

Reichert TE, Strauss L, Wagner EM, Gooding W, Whiteside TL.

Clin Cancer Res. 2002 Oct;8(10):3137-45.


Restored T-cell activation mechanisms in human tumour-infiltrating lymphocytes from melanomas and colorectal carcinomas after exposure to interleukin-2.

De Paola F, Ridolfi R, Riccobon A, Flamini E, Barzanti F, Granato AM, Mordenti GL, Medri L, Vitali P, Amadori D.

Br J Cancer. 2003 Jan 27;88(2):320-6.


Tumor-reactive CD4+ CD8αβ+ CD103+ αβT cells: a prevalent tumor-reactive T-cell subset in metastatic colorectal cancers.

Sarrabayrouse G, Corvaisier M, Ouisse LH, Bossard C, Le Mével B, Potiron L, Meurette G, Gervois N, Jotereau F.

Int J Cancer. 2011 Jun 15;128(12):2923-32. doi: 10.1002/ijc.25640. Epub 2010 Dec 1.


Analysis of T cell receptor variability in tumor-infiltrating lymphocytes from a human regressive melanoma. Evidence for in situ T cell clonal expansion.

Ferradini L, Mackensen A, Genevée C, Bosq J, Duvillard P, Avril MF, Hercend T.

J Clin Invest. 1993 Mar;91(3):1183-90.


Correlation between expression of cyclooxygenase-2 and the presence of CD4+ infiltrating T-lymphocyte in human primary hepatocellular carcinoma.

Gao YW, Chen YX, Wang ZM, Zhou LD, Li XY, Li LX, Luo QZ, Tian W, Fu CY, Zhou JH.

Hepatogastroenterology. 2008 Mar-Apr;55(82-83):345-50.


Tumor infiltrating lymphocytes: an intriguing player in the survival of colorectal cancer patients.

Deschoolmeester V, Baay M, Van Marck E, Weyler J, Vermeulen P, Lardon F, Vermorken JB.

BMC Immunol. 2010 Apr 12;11:19. doi: 10.1186/1471-2172-11-19.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk